Hemophilia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment
Conditions:   Male;   Hemophilia A With Inhibitor;   Hemophilia B With Inhibitor;   Hemophilia Intervention:   Drug: SS109 Sponsor:   Jiangsu Gensciences lnc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials